1. Home
  2. ZLAB vs ENIC Comparison

ZLAB vs ENIC Comparison

Compare ZLAB & ENIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • ENIC
  • Stock Information
  • Founded
  • ZLAB 2013
  • ENIC 2016
  • Country
  • ZLAB China
  • ENIC Chile
  • Employees
  • ZLAB N/A
  • ENIC N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • ENIC Electric Utilities: Central
  • Sector
  • ZLAB Health Care
  • ENIC Utilities
  • Exchange
  • ZLAB Nasdaq
  • ENIC Nasdaq
  • Market Cap
  • ZLAB 4.3B
  • ENIC 4.4B
  • IPO Year
  • ZLAB 2017
  • ENIC N/A
  • Fundamental
  • Price
  • ZLAB $34.96
  • ENIC $3.31
  • Analyst Decision
  • ZLAB Buy
  • ENIC Hold
  • Analyst Count
  • ZLAB 5
  • ENIC 2
  • Target Price
  • ZLAB $54.28
  • ENIC $3.90
  • AVG Volume (30 Days)
  • ZLAB 860.8K
  • ENIC 657.7K
  • Earning Date
  • ZLAB 08-07-2025
  • ENIC 07-29-2025
  • Dividend Yield
  • ZLAB N/A
  • ENIC 5.61%
  • EPS Growth
  • ZLAB N/A
  • ENIC N/A
  • EPS
  • ZLAB N/A
  • ENIC 0.00
  • Revenue
  • ZLAB $427,799,000.00
  • ENIC $4,054,679,917.00
  • Revenue This Year
  • ZLAB $45.16
  • ENIC $113,212.22
  • Revenue Next Year
  • ZLAB $56.81
  • ENIC $0.32
  • P/E Ratio
  • ZLAB N/A
  • ENIC $34.24
  • Revenue Growth
  • ZLAB 32.56
  • ENIC N/A
  • 52 Week Low
  • ZLAB $16.01
  • ENIC $2.51
  • 52 Week High
  • ZLAB $44.34
  • ENIC $4.05
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 45.24
  • ENIC 46.81
  • Support Level
  • ZLAB $33.17
  • ENIC $3.10
  • Resistance Level
  • ZLAB $39.64
  • ENIC $3.33
  • Average True Range (ATR)
  • ZLAB 1.19
  • ENIC 0.07
  • MACD
  • ZLAB -0.31
  • ENIC 0.02
  • Stochastic Oscillator
  • ZLAB 22.29
  • ENIC 70.69

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About ENIC Enel Chile S.A. (Each representing 50 shares of)

Enel Chile SA is an electricity utility company, which through its subsidiaries and affiliates is engaged in the generation, transmission and distribution of electricity businesses in Chile. It operates through two segments including Generation Business and Distribution and Network Business. The Generation Business Segment is comprised of a group of electricity companies that own electricity generating plants, whose energy is transmitted and distributed to end customers. The Distribution and Network Reportable Segment is comprised of a group of electricity companies operating under a public utility concession.

Share on Social Networks: